Does TREMELIMUMAB\TREMELIMUMAB-ACTL Cause Malignant neoplasm progression? 101 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 101 reports of Malignant neoplasm progression have been filed in association with TREMELIMUMAB\TREMELIMUMAB-ACTL. This represents 8.6% of all adverse event reports for TREMELIMUMAB\TREMELIMUMAB-ACTL.
101
Reports of Malignant neoplasm progression with TREMELIMUMAB\TREMELIMUMAB-ACTL
8.6%
of all TREMELIMUMAB\TREMELIMUMAB-ACTL reports
38
Deaths
12
Hospitalizations
How Dangerous Is Malignant neoplasm progression From TREMELIMUMAB\TREMELIMUMAB-ACTL?
Of the 101 reports, 38 (37.6%) resulted in death, 12 (11.9%) required hospitalization, and 6 (5.9%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREMELIMUMAB\TREMELIMUMAB-ACTL. However, 101 reports have been filed with the FAERS database.
What Other Side Effects Does TREMELIMUMAB\TREMELIMUMAB-ACTL Cause?
Diarrhoea (109)
Death (106)
Cytokine release syndrome (86)
Immune-mediated enterocolitis (63)
Liver disorder (62)
Pyrexia (61)
Rash (60)
Colitis (47)
Immune-mediated hepatic disorder (45)
Interstitial lung disease (41)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which TREMELIMUMAB\TREMELIMUMAB-ACTL Alternatives Have Lower Malignant neoplasm progression Risk?
TREMELIMUMAB\TREMELIMUMAB-ACTL vs TRENBOLONE
TREMELIMUMAB\TREMELIMUMAB-ACTL vs TREOSULFAN
TREMELIMUMAB\TREMELIMUMAB-ACTL vs TREPROSTINIL
TREMELIMUMAB\TREMELIMUMAB-ACTL vs TREPROSTINIL DIOLAMINE
TREMELIMUMAB\TREMELIMUMAB-ACTL vs TRETINOIN